Table 3 Demographic and clinical characteristics stratified by WC according ATPIII and IISHMS
| Â | All | WC-ATPIII | WC-IISHMS | ||
|---|---|---|---|---|---|
Off target | On target | Off target | On target | ||
(n = 9263) | (n = 7330) | (n = 1933) | (n = 8678) | (n = 585) | |
Age (years) | 64.3 ± 7.2 | 64.3 ± 7.2 | 64.3 ± 7.4 | 64.3 ± 7.2 | 64.2 ± 7.4 |
Gender | |||||
 Female | 3305 | 3050 (92.3 %) | 255 (7.7 %) | 3232 (97.8 %) | 73 (2.2 %) |
 Male | 5958 | 4280 (71.8 %) | 1678 (28.2 %) | 5446 (91.4 %) | 512 (8.6 %) |
Age group | |||||
 50–59 years | 2305 | 1822 (79.0 %) | 483 (21.0 %) | 2165 (93.9 %) | 140 (6.1 %) |
 60–69 years | 4806 | 3835 (79.8 %) | 971 (20.2 %) | 4501 (93.7 %) | 305 (6.3 %) |
 70–79 years | 1954 | 1518 (77.7 %) | 436 (22.3 %) | 1829 (93.6 %) | 125 (6.4 %) |
 80–89 years | 194 | 153 (78.9 %) | 41 (21.1 %) | 180 (92.8 %) | 14 (7.2 %) |
 90–99 years | 4 | 2 (50.0 %) | 2 (50.0 %) | 3 (75.0 %) | 1 (25.0 %) |
Region | |||||
 Europe | 3489 | 2873 (82.3 %) | 616 (17.7 %) | 3322 (95.2 %) | 167 (4.8 %) |
 Other areas | 2600 | 2053 (79.0 %) | 547 (21.0 %) | 2449 (94.2 %) | 151 (5.8 %) |
 United States | 2465 | 2092 (84.9 %) | 373 (15.1 %) | 2345 (95.1 %) | 120 (4.9 %) |
 Asia | 709 | 312 (44.0 %) | 397 (56.0 %) | 562 (79.3 %) | 147 (20.7 %) |
Race | |||||
 Asian | 919 | 420 (45.7 %) | 499 (54.3 %) | 741 (80.6 %) | 178 (19.4 %) |
 Black | 771 | 632 (82.0 %) | 139 (18.0 %) | 725 (94.0 %) | 46 (6.0 %) |
 Other | 403 | 298 (73.9 %) | 105 (26.1 %) | 374 (92.8 %) | 29 (7.2 %) |
 Caucasian | 7170 | 5980 (83.4 %) | 1190 (16.6 %) | 6838 (95.4 %) | 332 (4.6 %) |
Ethnicity | |||||
 Hispanic or latino | 1127 | 840 (74.5 %) | 287 (25.5 %) | 1070 (94.9 %) | 57 (5.1 %) |
 Not hispanic or latino | 8136 | 6490 (79.8 %) | 1646 (20.2 %) | 7608 (93.5 %) | 528 (6.5 %) |
eGFR category (mL/min/1.73Â m2) | |||||
 Normal (≥90) | 3415 | 2654 (77.7 %) | 761 (22.3 %) | 3183 (93.2 %) | 232 (6.8 %) |
 Mild (60–90) | 3831 | 3068 (80.1 %) | 763 (19.9 %) | 3590 (93.7 %) | 241 (6.3 %) |
 Moderate (30–60) | 1842 | 1475 (80.1 %) | 367 (19.9 %) | 1742 (94.6 %) | 100 (5.4 %) |
 Severe (<30) | 173 | 132 (76.3 %) | 41 (23.7 %) | 161 (93.1 %) | 12 (6.9 %) |
Smoker | |||||
 Current smoker | 1117 | 833 (74.6 %) | 284 (25.4 %) | 1023 (91.6 %) | 94 (8.4 %) |
 Never smoked | 3852 | 3057 (79.4 %) | 795 (20.6 %) | 3611 (93.7 %) | 241 (6.3 %) |
 Previous smoker | 4294 | 3440 (80.1 %) | 854 (19.9 %) | 4044 (94.2 %) | 250 (5.8 %) |
CVD stratum | |||||
 No prior CVD group | 1736 | 1398 (80.5 %) | 338 (19.5 %) | 1636 (94.2 %) | 100 (5.8 %) |
 Prior CVD group | 7527 | 5932 (78.8 %) | 1595 (21.2 %) | 7042 (93.6 %) | 485 (6.4 %) |
Diabetes duration (years) | 12.7 ± 8.0 | 12.5 ± 8.0 | 13.5 ± 8.3 | 12.6 ± 8.0 | 13.9 ± 8.7 |
HbA1c (%) | 8.7 ± 1.5 | 8.7 ± 1.5 | 8.7 ± 1.6 | 8.7 ± 1.5 | 8.7 ± 1.7 |
HbA1c (mmol/mol) | (71.6 ± 16.4) | (71.6 ± 16.4) | (71.6 ± 17.5) | (71.6 ± 16.4) | (71.6 ± 18.6) |
Blood lipids | |||||
 LDL-C (mmol/L) | 2.3 ± 0.9 | 2.3 ± 0.9 | 2.3 ± 0.9 | 2.3 ± 0.9 | 2.2 ± 0.9 |
 HDL-C (mmol/L) | 1.2 ± 0.3 | 1.2 ± 0.3 | 1.2 ± 0.3 | 1.2 ± 0.3 | 1.3 ± 0.4 |
 Triglycerides (mmol/L) | 2.1 ± 1.6 | 2.1 ± 1.6 | 1.7 ± 1.5 | 2.1 ± 1.6 | 1.6 ± 1.6 |
Blood pressure | |||||
 Systolic blood pressure (mmHg) | 138 ± 19 | 138 ± 19 | 136 ± 19 | 138 ± 19 | 135 ± 18 |
 Diastolic blood pressure (mmHg) | 78 ± 11 | 78 ± 11 | 77 ± 10 | 78 ± 11 | 76 ± 10 |